Cytokinetics (CYTK) Tops Q2 EPS by 13c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $81.37 +3.20%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
ARTNA, REFR, DFTX, More
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
ARTNA, REFR, DFTX, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q2 EPS of ($1.50), $0.13 better than the analyst estimate of ($1.63). Revenue for the quarter came in at $28.6 million versus the consensus estimate of $17.09 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Perdoceo Education Corp. (PRDO) Tops Q2 EPS by 9c; Offers Guidance
- Corvus Pharmaceuticals, Inc. (CRVS) Misses Q2 EPS by 4c
- Cytosorbents (CTSO) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
